Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1981
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1981
Report date:
1981

Materials and methods

Principles of method if other than guideline:
The micronucleus test was employed to investigate 4-trifluoromethoxyphenyl isocyanate in male and female mice for a possible clastogenic effect on the chromosomes of bone-marrow erythroblasts. The known clastogen and cytostatic agent, Trenimon, served as positive control. The treated animals received 2 oral application within 24 hoursof the test substance, the positive control was applied intraperitoneal. The femoral marrow of groups treated with 4-trifluoromethoxyphenyl isocyanate was prepared 6 hours after administration.
GLP compliance:
no
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
p-(trifluoromethoxy)phenyl isocyanate
EC Number:
252-328-0
EC Name:
p-(trifluoromethoxy)phenyl isocyanate
Cas Number:
35037-73-1
Molecular formula:
C8H4F3NO2
IUPAC Name:
1-isocyanato-4-(trifluoromethoxy)benzene
Details on test material:
content: 99.78%

Test animals

Species:
mouse
Strain:
other: Bor: NMRI (SPF Han)
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Duration of treatment / exposure:
2 oral treatments within 24 hours
Frequency of treatment:
2 oral treatments within 24 hours
Post exposure period:
Animals were sacrificed 6 after the second application
Doses / concentrationsopen allclose all
Dose / conc.:
100 mg/kg bw/day (nominal)
Remarks:
2 x 100 mg/kg bw
Dose / conc.:
50 mg/kg bw/day (nominal)
Remarks:
2 x 50 mg/kg bw

No. of animals per sex per dose:
5 male and 5 female mice/group
Control animals:
yes, concurrent vehicle

Examinations

Tissues and cell types examined:
femoral marrow

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
yes
Remarks:
in the 2 x 50 mg/kg bw no signs of toxicity; in the 2 x 100 mg/kg bw group 11 of 20 animals died
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid

Any other information on results incl. tables

No signs for a mutagenic effect of 4-trifluoromethoxyphenyl isocyanate in doses up to 2 x 100 mg/kg bw was evident. No relevant, treatment related alteration of the ratio polychromatic to normochromatic erythrocytes was found. the positive control (Tremonin) had a clear mutagenic effect.

Applicant's summary and conclusion

Conclusions:
No signs for a mutagenic effect of 4-trifluoromethoxyphenyl isocyanate in doses up to 2 x 100 mg/kg bw was evident. No relevant, treatment related alteration of the ratio polychromatic to normochromatic erythrocytes was found. the positive control (Tremonin) had a clear mutagenic effect. Under the conditions of the test 4-trifluoromethoxyphenyl isocyanate was negative in the in-vivo micronucleus test.
Executive summary:

The micronucleus test was employed to investigate 4-trifluoromethoxyphenyl isocyanate in male and female mice for a possible clastogenic effect on the chromosomes of bone-marrow erythroblasts. The known clastogen and cytostatic agent, Trenimon, served as positive control. The treated animals received 2 oral application of the test substance within 24 hours, the positive control was applied intraperitoneal. The femoral marrow of groups treated with 4-trifluoromethoxyphenyl isocyanate was prepared 6 hours after administration.


No signs for a mutagenic effect of 4-trifluoromethoxyphenyl isocyanate in doses up to 2 x 100 mg/kg bw was evident. No relevant, treatment related alteration of the ratio polychromatic to normochromatic erythrocytes was found. the positive control (Tremonin) had a clear mutagenic effect. Under the conditions of the test 4-trifluoromethoxyphenyl isocyanate was negative in the in-vivo micronucleus test.